Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes
about
Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer developmentThe level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic reviewHealth information technology in oncology practice: a literature reviewMeasuring the symptom burden associated with the treatment of chronic myeloid leukemiaSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsA framework for understanding cancer comparative effectiveness research data needsEnhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial.Improving symptom communication through personal digital assistants: the CHAT (Communicating Health Assisted by Technology) project.Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs.Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial.Do we reach the patients with the most problems? Baseline data from the WebCan study among survivors of head-and-neck cancer, Denmark.Quantitative tool to evaluate the somatic burden due to chemotherapy-induced adverse events: the somatic burden score.Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT.Manifesto: towards a clinically-oriented psychometrics.Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatmentReview of electronic patient-reported outcomes systems used in cancer clinical care.Adverse events following trigger point dry needling: a prospective survey of chartered physiotherapists.The use of erlotinib in daily practice: a study on adherence and patients' experiences.Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).Ongoing challenges in pharmacovigilance.Development and preliminary evaluation of a training workshop for the collection of patient-reported outcome (PRO) interview data by research support staff.The missing voice of patients in drug-safety reporting.Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.Structured decision-making: using personalized medicine to improve the value of cancer care.A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatmentAssociation of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy.Improving modern cancer care through information technologyWhy do patients with cancer visit emergency departments? Results of a 2008 population study in North CarolinaThe role of informatics in promoting patient-centered care.Cancer-related and treatment-related fatigue.Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survivalAdherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer.Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.Evaluation of electronic patient-reported outcome assessment with cancer patients in the hospital and at homeAssessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09).Systematic collection of patient reported outcome research data: A checklist for clinical research professionals.
P2860
Q24616554-164D55D7-79F1-449A-931A-22B27354A08EQ26796534-14A00779-1781-4D3B-8C60-59AA97ED53F5Q27002368-AEA4B9BC-AA2E-4018-A869-CAEB6D424BDAQ28689231-4302CC08-A0CA-4D2E-9D8E-CB1D67E9E259Q28710019-E3F3608B-CAA6-475F-9DAE-20B29E803473Q30416607-D927022F-E8CA-4432-A3A8-EDD894B43C8FQ30499257-6303871A-A3FA-49DA-8BB3-1A34590742C9Q30562213-8D9D2BC0-B62F-4DD9-BF24-A81D3CAF2F26Q30565997-971776D8-8682-4DE3-A6A6-E29008B30260Q30583850-9F09D73D-2364-476C-AAA8-B10CB25D30B4Q30620556-747A3C83-79D7-4857-AE32-644A090254B7Q30984056-8787F76C-4A17-4953-BC9D-AD441EE0BF6BQ33416289-0D8B500A-7E32-4C2F-9905-F1B0A8DD068CQ33448663-54ABE36D-BA75-4D81-A7D8-12F1A91B3C72Q33608740-D5F974E3-7BCE-489B-AA83-2285B8A4C570Q33647002-E118EBC6-3C65-4540-A4E9-8EC283F6FC76Q33890495-CE6ECD3D-264A-42EB-B7E8-228FD86A32DDQ33912777-F05F6839-C9A3-4875-995F-3714FF302381Q33948681-3725A790-1A10-40AE-A5D4-23EDB6E24076Q34035015-31A83B60-8F4B-4389-A73B-54D96E238FB7Q34354355-47733E1C-1485-480C-A4B8-BFF417FD4529Q34417013-9A134582-1AFC-4341-93B0-7C135BEBD789Q34454835-650559CA-A4CF-483B-B874-43F6B40989D7Q34544023-AFFD5755-1535-4E90-A178-49B745CEB27FQ34571228-65EE5FC3-BC87-424A-B36D-FF34F53B07D6Q34608684-5F4B2A25-867D-4876-BA34-AF63B60CD8CCQ34987417-A8B8B215-2B35-4C9B-AF89-61E3BDB6516EQ35029533-58681CDA-86FC-4825-B911-274AFBEBE397Q35048101-C5DB714F-DB65-48F9-989C-9D9A948C9C1BQ35057370-2A330010-3397-4CCF-AE29-23F3868DACE2Q35114455-275340F6-13A0-4C07-8D35-A4C286629248Q35137693-A337D365-0093-42DF-826B-12B3CFEB3903Q35164501-B7C0D38A-B352-4A05-BF18-D2ED1450FD48Q35248222-86BB1BAB-AAF1-4EEA-91A1-0836375D9836Q35626586-CB8E6DA0-8048-4932-AB95-2F8B7AB6B831Q35749286-56F29ABB-CA87-43C5-A541-CBCC86DD9828Q35812261-FDE25448-553D-4EB4-8A7B-8C01C9BC9747Q35877306-0CB7CFF6-6DE5-433E-ADFC-43871E5D7AF9Q35921124-BC547F9D-197E-43E2-BD3F-D706D2A7FDECQ35965743-FA617911-BF48-439F-943C-1C2379A27215
P2860
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Adverse symptom event reportin ...... onships with clinical outcomes
@en
Adverse symptom event reportin ...... nships with clinical outcomes.
@nl
type
label
Adverse symptom event reportin ...... onships with clinical outcomes
@en
Adverse symptom event reportin ...... nships with clinical outcomes.
@nl
prefLabel
Adverse symptom event reportin ...... onships with clinical outcomes
@en
Adverse symptom event reportin ...... nships with clinical outcomes.
@nl
P2093
P2860
P356
P1476
Adverse symptom event reportin ...... onships with clinical outcomes
@en
P2093
Alexia Iasonos
Allison Barz
Ann Culkin
Deborah Schrag
Glenn Heller
Mark Appawu
Mark G Kris
Michael Fruscione
Shari Goldfarb
P2860
P304
P356
10.1093/JNCI/DJP386
P407
P50
P577
2009-11-17T00:00:00Z